Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: J Card Fail. 2009 Sep 3;16(1):55. doi: 10.1016/j.cardfail.2009.07.002

Table 2.

Association of CystatinC with Atrial Fibrillation

Measure and Outcome Quartile I Quartile 2 Quartile 3 Quartile 4
Cystatin C and
Prevalent AF
Range of Values —
mg/liter
≤0.92 0.93-1.05 1.06-1.22 ≥1.23
 No. 1172 1227 1108 1156
No. with prevalent
atrial fibrillation
48 66 97 131
Odds Ratio (95% CI)
 Unadjusted 1.00 1.19 (0.80-1.76) 2.00 (1.38-2.88) 2.87 (2.03-4.07)
 Adjusted* 1.00 1.05 (0.71-1.57) 1.52 (1.03-2.23) 1.53 (1.03-2.28)
Cystatin C and
Incident AF
Range of Values —
mg/liter
≤0.92 0.93-1.05 1.06-1.22 ≥1.23
 No. at risk 1124 1161 1011 1025
 No. with incident atrial
 Fibrillation
111 162 141 165
Hazard Ratio (95% CI)
 Unadjusted 1.00 1.37 (1.07-1.75) 1.43 (1.11-1.84) 1.88 (1.47-2.41)
 Adjusted* 1.00 1.21 (0.95-1.55) 1.11 (0.85-1.44) 1.14 (0.87-1.50)
*

Adjusted for age, gender, race, diabetes , CRP, LDL, HDL, prevalent CHD, prevalent CHF, left ventricular hypertrophy, SBP, DBP, use of angiotensin converting enzyme inhibitor, beta blocker, calcium channel blocker and diuretic.